• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶原片段1+2是接受治疗的高血压男性发生心肌梗死的一个危险因素。

Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.

作者信息

Agewall S, Wikstrand J, Fagerberg B

机构信息

Department of Medicine, Sahlgrenska University Hospital, Göteborg University, Sweden.

出版信息

J Hypertens. 1998 Apr;16(4):537-41. doi: 10.1097/00004872-199816040-00016.

DOI:10.1097/00004872-199816040-00016
PMID:9797200
Abstract

BACKGROUND

Haemostatic factors may play a part in the development of acute coronary heart disease.

OBJECTIVE

To evaluate as predictors of major coronary events (fatal and non-fatal myocardial infarctions and sudden death) levels of fibrinogen, von Willebrand factor, prothrombin fragment 1+2, thrombin-antithrombin complex, plasminogen activator inhibitor activity and C-reactive protein.

METHODS

We studied 131 men, aged 56-77 years, with treated hypertension and at least one additional cardiovascular risk factor (hypercholesterolaemia, diabetes mellitus or smoking). These patients were recruited from a continuing risk factor intervention study. The mean observation time was 3.0 years.

RESULTS

Fourteen patients died and 16 had a major coronary event during the follow-up period. After adjustments for other risk factors, levels of prothrombin fragment 1+2 and C-reactive protein were independent predictors of major coronary events. The other measured haemostatic variables were not significantly associated with major coronary events during follow-up. Fibrinogen and prothrombin fragment 1+2 levels were independent predictors for mortality.

CONCLUSIONS

Among treated hypertensive men, levels of prothrombin fragment 1+2 and C-reactive protein were independent predictors of major coronary events.

摘要

背景

止血因子可能在急性冠状动脉疾病的发生发展中起作用。

目的

评估纤维蛋白原、血管性血友病因子、凝血酶原片段1+2、凝血酶-抗凝血酶复合物、纤溶酶原激活物抑制剂活性及C反应蛋白水平作为主要冠状动脉事件(致命和非致命性心肌梗死及猝死)预测指标的价值。

方法

我们研究了131名年龄在56至77岁之间、患有高血压且至少还有一种其他心血管危险因素(高胆固醇血症、糖尿病或吸烟)的男性。这些患者来自一项持续的危险因素干预研究。平均观察时间为3.0年。

结果

随访期间,14名患者死亡,16名发生主要冠状动脉事件。在对其他危险因素进行校正后,凝血酶原片段1+2水平和C反应蛋白水平是主要冠状动脉事件的独立预测指标。其他检测的止血变量在随访期间与主要冠状动脉事件无显著相关性。纤维蛋白原和凝血酶原片段1+2水平是死亡率的独立预测指标。

结论

在接受治疗的高血压男性中,凝血酶原片段1+2水平和C反应蛋白水平是主要冠状动脉事件的独立预测指标。

相似文献

1
Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.凝血酶原片段1+2是接受治疗的高血压男性发生心肌梗死的一个危险因素。
J Hypertens. 1998 Apr;16(4):537-41. doi: 10.1097/00004872-199816040-00016.
2
Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.凝血酶原片段1+2是接受治疗的高血压男性发生心肌梗死的一个危险因素。
J Hypertens. 1998 Oct;16(10):1557-9.
3
Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction.凝血酶原片段 1 + 2 与心肌梗死患者颈动脉内膜中层厚度相关。
Thromb Res. 2009 Nov;124(5):526-30. doi: 10.1016/j.thromres.2009.03.014. Epub 2009 May 8.
4
Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease.颈动脉壁形态、止血因素与心血管疾病。一项针对动脉粥样硬化疾病高风险和低风险男性的超声研究。
Blood Coagul Fibrinolysis. 1994 Dec;5(6):895-904. doi: 10.1097/00001721-199412000-00005.
5
Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.心肌梗死后凝血活性早期降低与新发缺血性事件风险较低相关:来自ESTEEM试验的观察结果
Eur Heart J. 2007 Mar;28(6):692-8. doi: 10.1093/eurheartj/ehl564. Epub 2007 Feb 21.
6
Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.凝血酶原片段1+2是接受治疗的男性高血压患者发生心肌梗死的一个危险因素。
J Hypertens. 1998 Oct;16(10):1555.
7
Prothrombin fragment 1 + 2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients.微量白蛋白尿型2型糖尿病患者的凝血酶原片段1+2和抗凝血酶III-凝血酶复合物
Diabet Med. 1994 Jun;11(5):485-8. doi: 10.1111/j.1464-5491.1994.tb00311.x.
8
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.肌酐清除率降低的高血压患者的凝血异常。
Am J Med. 2000 Nov;109(7):556-61. doi: 10.1016/s0002-9343(00)00567-2.
9
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.止血因素与心绞痛患者心肌梗死或猝死风险。欧洲血栓形成与残疾协同行动心绞痛研究组
N Engl J Med. 1995 Mar 9;332(10):635-41. doi: 10.1056/NEJM199503093321003.
10
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction.经冠状动脉内注射骨髓细胞对急性心肌梗死患者促血栓形成标志物的影响。
Thromb Res. 2012 Nov;130(5):765-8. doi: 10.1016/j.thromres.2011.11.045. Epub 2011 Dec 20.

引用本文的文献

1
Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle.血栓形成、转化医学与生物标志物研究:取得进展
J Am Heart Assoc. 2025 Jan 7;14(1):e038782. doi: 10.1161/JAHA.124.038782. Epub 2024 Dec 24.
2
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.与C反应蛋白水平及冠心病风险相关的基因位点
JAMA. 2009 Jul 1;302(1):37-48. doi: 10.1001/jama.2009.954.
3
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.低度炎症与冠心病:前瞻性研究及更新的荟萃分析
BMJ. 2000 Jul 22;321(7255):199-204. doi: 10.1136/bmj.321.7255.199.